[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344357-105":59,"doc-detail-344357-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","fraction-of-cancer-attributable-to-carcinogenic-drugs-in-korea-from-2015-to-2030","Fraction of Cancer Attributable to Carcinogenic Drugs in Korea from 2015 to 2030","","Study estimates and projects the population attributable fraction (PAF) of cancer incidence and death due to carcinogenic drug use in Korea from 2015 to 2030, quantifying how much cancer prevention could come from reduced exposure. Carcinogenic drugs are defined as group I by IARC and include immunosuppressive and antineoplastic agents. A systematic review and meta-analysis derive relative risks, then calculate PAF using Levin’s formula with Monte Carlo simulation and prevalence extrapolation. In 2015, attributable fractions are extremely low overall but higher in clinically indicated patients, with a rapidly increasing trend expected.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/fraction-of-cancer-attributable-to-carcinogenic-drugs-in-korea-from-2015-to-2030/344357/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/fraction-of-cancer-attributable-to-carcinogenic-drugs-in-korea-from-2015-to-2030/344357.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study estimate for Korea from 2015 to 2030?","Question",{"text":112,"@type":113},"It estimates and projects the population attributable fraction (PAF) of cancer incidence and death attributable to carcinogenic drug use over 2015–2030.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are carcinogenic drugs defined in this research?",{"text":117,"@type":113},"They are immunosuppressive and antineoplastic drugs classified as group I by the International Agency for Research on Cancer (IARC).",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings about attributable fractions?",{"text":121,"@type":113},"In 2015, carcinogenic drugs accounted for very small fractions of cancer incidence and death overall, but attributable fractions were much higher in patients with clinical indications of these drugs, with an expected rapid increase over time.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344357,1790781251,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","[https://doi.org/10.4143/crt.2024.644](https://doi.org/10.4143/crt.2024.644) Cancer Res Treat. 2025;57(3):635-648  \nOriginal Article  \nFraction of Cancer Attributable to Carcinogenic Drugs in Korea from 2015 to 2030  \nWoojin Lim1,2,3 , Soseul Sung1,2,3 , Youjin Hong1,2,4 , Sungji Moon1,2,5 , Sangjun Lee1,2,4 , Kyungsik Kim1,2 , Jung Eun Lee6 , Inah Kim7 , Kwang-Pil Ko8 , Sue K. Park1,2,4  \n1Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, 2Cancer Research Institute, Seoul National University, Seoul, 3Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, 4Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, 5Interdisciplinary Program in Cancer Biology, Seoul National University College of Medicine, Seoul, 6Department of Food and Nutrition, Seoul National University College of Human Ecology, Seoul, 7Department of Occupational and Environmental Medicine, Hanyang University College of Medicine, Seoul, 8Clinical Preventive Medicine Center, Seoul National University Bundang Hospital, Seongnam, Korea  \nPurpose This study aims to estimate and project the population attributable fraction (PAF) of cancer incidence and death due to carcinogenic drug use in Korea from 2015 to 2030, to estimate the degree of cancer prevention from exposure to carcinogenic drugs in Korea. Selected carcinogenic drugs were immunosuppressive and antineoplastic drugs classified as group I by the International Agency for Research on Cancer.  \nMaterials and Methods Systematic review and meta-analyses were conducted to estimate the relative risk of cancer associated with carcinogenic drug use. Age was standardized using the annual prevalence rate of the National Health Insurance Service sample cohort (NHIS-NSC) from 2002 to 2013 to calculate the standardized prevalence rate of carcinogenic drug use each year. The PAF of specific cancer incidence and death were calculated using Levin’s formula and Monte Carlo methods. The prevalence rates were extrapolated to estimate the trend of PAF from 2015 to 2030.  \nResults In 2015, carcinogenic drugs attributed to 0.003% and 0.002% among the causes of cancer incidence and death in Korea. However, carcinogenic drugs attributed to 1.1% among the causes of both cancer incidence and death in patients with clinical indications of carcinogenic drugs.  \nConclusion The PAF in patients with clinical indications of carcinogenic drugs were significantly high and expected to increase rapidly over time. Since these drugs are listed as essential by the World Health Organization, and may be difficult to replace, a surveillance system on susceptible populations using group I carcinogenic drugs must be discussed and implemented.  \nKey words Population attributable fraction, Attributable count, Carcinogenic drugs  \nIntroduction  \nSince its establishment in 1965, the International Agency for Research on Cancer (IARC), under the World Health Organization, has been conducting research to collect evidence on the risk factors of cancer in humans. Since the publication of its first 16-volume monograph series in 1971, IARC has been continuously updating the contents. Out of the monograph series published by IARC since 1971, a total of 5 were solely about the risk of cancer from various drugs, emphasizing the importance of assessing the cancer risk from these risk factors [1-5] .  \nIn the IARC monograph, factors were categorized into groups according to the sufficiency of evidence regarding their carcinogenicity in humans, and each factor’s risk level and need for additional research were provided. Among them, factors with sufficient evidence for causing cancer in humans are defined as group I.  \nThese group I carcinogenic drugs consist of immunosuppressants used for organ transplants, prevention of chronic allograft rejection, and inflammatory bowel diseases (Crohn’s disease, ulcerative colitis) . Group I drug also consist of alkylatin","cbCaijFJ8qrgr4fA","https://ap.wps.com/l/cbCaijFJ8qrgr4fA","pdf",1007726,14,"English","# Purpose\n# Materials and Methods\n## Relative risk estimation and PAF calculation\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"What does the study estimate for Korea from 2015 to 2030?\",\"answer\":\"It estimates and projects the population attributable fraction (PAF) of cancer incidence and death attributable to carcinogenic drug use over 2015–2030.\"},{\"question\":\"How are carcinogenic drugs defined in this research?\",\"answer\":\"They are immunosuppressive and antineoplastic drugs classified as group I by the International Agency for Research on Cancer (IARC).\"},{\"question\":\"What were the key findings about attributable fractions?\",\"answer\":\"In 2015, carcinogenic drugs accounted for very small fractions of cancer incidence and death overall, but attributable fractions were much higher in patients with clinical indications of these drugs, with an expected rapid increase over time.\"}]","Fraction of Cancer Attributable to Carcinogenic Drugs in Korea from 2015 to 2030 | PDF",1790053461,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30dcc6381fbe82e5900c8ef69723351e.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/019e806fad012376b05ba13a396f5148.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67ffe4d5c93ae2357dd36a9cb298486c.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3c093cda61c2b7769c545d9dd5badef.webp",980,1306]